Company intelligence / Profile preview
Jianming Pharmaceutical Group
Wuhan, Hubei, Chinawhjm.com ↗
- Ownership
- Private
- Employees
- ~2345
- Development stage
- Other
01
Overview
Jianmin Pharmaceutical Group is a long‑established Chinese pharmaceutical company, commercial with NMPA‑approved traditional Chinese medicines and chemical drugs, and at least one product (Qinqiao Yanshu granules) in Phase 2 clinical development for acute pharyngitis.
- Therapeutic areas
- HematologyWomen's HealthEndocrinologyCardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
- Modalities
- Small moleculeHerbal medicineTraditional Chinese medicineBiologic
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
111 Inc. - Strategic cooperation to build chronic disease management platform and distribute Jianmin products (especially liver and gallbladder medications) through 111’s online network.
Beyond the preview
Go deeper on Jianming Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jianming Pharmaceutical Group.